Jump to content

COVID and medial research


Recommended Posts

 

1 hour ago, Hans de Vries said:

The vaccines went from phase 1 trial to approval in 1 year.

I don't know about elsewhere, but COVID vaccines are not approved in the US. They are being used under an emergency use authorization (EUA)

 

The issuance of an EUA is different than an FDA approval (licensure) of a vaccine, in that a vaccine available under an EUA is not approved. In determining whether to issue an EUA for a product, the FDA evaluates the available evidence to determine whether the product may be effective and also assesses any known or potential risks and any known or potential benefits. 

https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid

Link to post
Share on other sites

Pretty much the same everywhere. Process is not faster, just the approval due to the emergency. It also means we have led data than for regular vaccines. What it did, however was focus more efforts into a single disease, which otherwise would have spread across different research questions.

Link to post
Share on other sites
  • 1 month later...

Nature of true original science is NOT hasty. they just needed some vaccine to soothe the populace. Not exactly clear how successful this shall turn out to be. Let alone in other less attractive , less  "important"  fields . . .  .. .

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.